Alphamab Oncology's total assets for Q2 2024 were ¥2.14B, an increase of 0.23% from the previous quarter. HK:9966 total liabilities were ¥513.25M for the fiscal quarter, a 10.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.